NerveGen .: Photopolymerizable biodegradable copolymers for biomedical applications (Q2866737)
Jump to navigation
Jump to search
Project Q2866737 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | NerveGen .: Photopolymerizable biodegradable copolymers for biomedical applications |
Project Q2866737 in Portugal |
Statements
42,500.0 Euro
0 references
50,000.0 Euro
0 references
85.0 percent
0 references
4 June 2019
0 references
3 June 2021
0 references
UNIVERSIDADE DE COIMBRA
0 references
Q2988597 (Deleted Item)
0 references
40°12'40.28"N, 8°25'46.06"W
0 references
Pretende-se promover a transferência do conhecimento valorizando resultados que podem ser transformados em produtos inovadores com especial aplicação em novos tratamentos na área da saúde nomeadamente na disciplina da medicina regenerativa, através da proteção da tecnologia por pedido de patente. (Portuguese)
0 references
It aims to promote the transfer of knowledge by valuing results that can be transformed into innovative products with special application in new treatments in the area of health, namely in the discipline of regenerative medicine, through the protection of technology by patent application. (English)
7 July 2021
0 references
L’objectif est de promouvoir le transfert de connaissances en valorisant les résultats qui peuvent être transformés en produits innovants avec application spéciale dans de nouveaux traitements dans le domaine de la santé, en particulier dans la discipline de la médecine régénératrice, par la protection de la technologie par demande de brevet. (French)
4 December 2021
0 references
Ziel ist es, den Wissenstransfer zu fördern, indem Ergebnisse bewertet werden, die in innovative Produkte mit besonderer Anwendung in neue Behandlungen im Gesundheitsbereich, insbesondere in der Disziplin der regenerativen Medizin, durch den Schutz der Technologie durch Patentanmeldung umgewandelt werden können. (German)
13 December 2021
0 references
Het doel is de overdracht van kennis te bevorderen door resultaten te waarderen die kunnen worden omgezet in innovatieve producten met speciale toepassing bij nieuwe behandelingen op het gebied van gezondheid, met name in de discipline van de regeneratieve geneeskunde, door de bescherming van technologie door middel van octrooiaanvragen. (Dutch)
18 December 2021
0 references
Coimbra
0 references
Identifiers
CENTRO-01-0145-FEDER-045447
0 references